Spartan Enterprises Inc. dba Watershed Wellness Center – FDA Warning Letter, Oct 28, 2020
On October 30, 2020, the FDA and FTC issued a Warning Letter to Watershed Wellness regarding the sale of "Dissolve BioActive Silicate" and silver-containing products on their website, https://watershed.net, and social media, https://www.facebook.com/WatershedWellness and https://www.youtube.com/user/watershed11. The agencies reviewed these sites on October 7 and October 28, 2020.
The products are marketed with claims to mitigate, prevent, treat, diagnose, or cure COVID-19, making them unapproved new drugs under section 505(a) of the FD&C Act, 21 U.S.C. § 355(a), and misbranded drugs under section 502, 21 U.S.C. § 352. The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d), 21 U.S.C. § 331(a) and (d).
The letter highlights the ongoing COVID-19 public health emergency and national emergency declarations. Watershed Wellness is required to immediately cease selling these unapproved and unauthorized products for COVID-19 related uses. Within 48 hours, the company must email COVID-19-Task-Force-CDER@fda.h
- Inspection date
- October 28, 2020
- Product type
- Drugs
ID · ceb2f507-56c2-4984-a33c-51951c19ca09
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.